Try our Advanced Search for more refined results
July 19, 2018
Staublein v. Acadia Pharmaceuticals Inc. et al
Case Number:
3:18-cv-01647
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Block & Leviton
- Cooley LLP
- Glancy Prongay
- Kahn Swick
- Kessler Topaz
- Levi & Korsinsky
- Pomerantz LLP
- Robbins Geller
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 02, 2020
Acadia Can't Slip Investor Suit Over Parkinson's Drug Deaths
Acadia Pharmaceuticals escaped part of the securities fraud claims lodged in a proposed class action over its alleged cover-up of fatality risks associated with its Parkinson's disease treatment, but it must still face the bulk of the suit, a California federal court ruled Monday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login